InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Vellanki Avanish, 首席执行官. Director active across 2 companies, notably Rain Therapeutics Inc.. Cumulatively, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €54k. History available since 11 March 2022. The latest transaction was disclosed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Vellanki Avanish is Chairman and CEO of Rain Therapeutics Inc. and Rain Oncology Inc. He has 4 filings in total, and across the 4 recent filings held, purchases total EUR 53735 and sales EUR 0, over the period from 2022-03-15 to 2024-01-26.